secwatch.observer — SEC 8-K summary
======================================

Issuer:     Electromed, Inc. (ELMD)
CIK:        0001488917
Form:       8-K
Filed at:   2024-11-12T23:59:59+00:00
Accession:  0000897101-24-000562
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Electromed Q1 FY2025 revenue up 19% to $14.7M; net income $1.5M vs $0.2M YoY
----------------------------------------------------------------------------

- Diluted EPS $0.16 vs $0.02 prior year; operating income $1.9M (13.2% rev) vs $0.1M.
- Gross margin improved to 78.3% from 77.1%; direct homecare revenue rose 18.5% to $13.2M.
- Repurchased 262,756 shares for ~$4.5M at avg $17.26; $0.5M remaining on $5M authorization.
- Direct sales force of 53 reps; hired VP Marketing Peter Horwich; launched Triple Down on Bronchiectasis campaign.
- Cash $13.9M, no debt; annualized homecare revenue per rep $985,000 (within $900k-$1M target).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1488917/000089710124000562/0000897101-24-000562-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1488917/000089710124000562/elmd241175_8k.htm
  HTML page:      https://secwatch.observer/filing/0000897101-24-000562

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer